Even though BioMarin Pharmaceutical Inc. ( NASDAQ:BMRN ) posted strong earnings, investors appeared ...
Entropy Technologies LP lifted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Repo...
BioMarin Pharmaceutical delivered a second quarter that surpassed Wall Street’s expectations, with m...
Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) reported Q2 CY2025 results topping the market’...
BioMarin Pharmaceutical's (NYSE:BMRN) short percent of float has fallen 15.79% since its last report...